ArticleCurrent medical research and opinion2018

Developing an instrument to assess patient preferences for benefits and risks of treating acute myeloid leukemia to promote patient-focused drug development.

Jaein Seo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.